Cardiolyse - Patient Monitoring Europe Solutions/Service Company
healthcaretechoutlook

Cardiolyse : Comprehensive Heart Health Analytics for Saving Lives

Follow Cardiolyse on :

Anna Starynska, Co-Founder & CEO, CardiolyseAnna Starynska, Co-Founder & CEO, Cardiolyse
The COVID-19 pandemic has been one of the major catalysts behind refocusing the spotlight on remote patient monitoring systems and solutions. Especially with the need for social distancing, remote patient monitoring systems have become essential than ever as they enable physicians and clinicians to monitor patients without having to come into prolonged contact with them. In this background, Cardiolyse—a cloud electrocardiogram (ECG) and heart rate variability (HRV) analytics platform provider—is leveraging the power of the cloud and AI to take remote patient monitoring to the next level.

According to Anna Starynska, Co-Founder and CEO of Cardiolyse, “Global healthcare is in obvious and desperate need of disruptive technologies that will support its digital transformation to serve the emerging challenges of both healthcare providers and personal health-conscious patients.”

This is precisely what Cardiolyse offers to the healthcare realm. Today, the company’s platform is enabling healthcare clients to conduct real-time remote heart health monitoring, while providing them with simple personalised reports, detection, and data-based prediction on dangerous heart events. “Our primary goal here is to provide timely and data-driven insights for physicians and cardiologists to support the cost-effective patient-centric diagnosticating approach and more accurate self-care solutions for patients,” says Anna.


Cardiolyse is a cloud electrocardiogram (ECG) & heart rate variability (HRV) analytics platform that enables real-time remote heart health monitoring providing plain personalised reports, detection, and data-based prediction on dangerous heart events

Notably, Cardiolyse’s platform leverages proprietary machine-learning algorithms to process all vital ECG parameters and facilitate an alerting feature, enabling the treatment and prevention of critical heart-related events up to two months before they occur. As a device-agnostic cloud platform, Cardiolyse cuts off the need for complicated, time-consuming integration by pairing its solution with any type of digital ECG device via a universal application programming interface (API). The ecosystem comprises customised web dashboards for patients and physicians, as well as independent Android and iOS applications for each user type needs.

The platform’s capabilities don’t end there. It also detects the early trend of increased cardiovascular risk, allowing diabetes patients to effectively manage their conditions and prevent long-term cardiovascular complications. And it also provides fatigue risk management—a solution that provides the seamless real-time measurement of fatigue risks and alerts the supervisory control room and the user on potential increase in fatigue levels to prevent accidents.

Owing to these capabilities, and their contribution to patient care amid the pandemic, Cardiolyse is witnessing rapid growth and acceptance in the healthcare arena. To further enhance its offerings, the company will focus on leveraging its rich and extensive experience in the domain to further augment its platform. Moving ahead with this undeterred momentum, Cardiolyse is poised to provide a realistic and measurable control that makes real-time remote patient monitoring a success.

Share this Article:
Top 10 Patient Monitoring Solution Companies in Europe - 2021

Company
Cardiolyse

Headquarters
Helsinki, Finland

Management
Anna Starynska, Co-Founder & CEO , Cardiolyse

Description
Cardiolyse deploys its namesake platform; proprietary patent machine-learning algorithms to process all vital ECG parameters and to create an alerting feature. It also notifies both patient and his doctor on increased stroke or heart attack risks, enabling the prevention of critical heart events up to two months before they occur Cardiolyse also detects the early trend of increased cardiovascular risk, allowing diabetes patients to effectively manage their conditions and prevent long-term cardiovascular complications. And it also provides fatigue risk management—a solution that provides the seamless real-time measurement of fatigue risks and alerts the supervisory control room and the user on potential increase in fatigue levels to prevent accidents